Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2Phase EARLY_PHASE1 1Phase 3 1

Status

Completed 2Active not recruiting 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 4NETWORK 2

Study Type

Interventional 6

Sponsor

Cancer Type

Plasma cell 7Breast 6Lymphoid 5Other hematologic neoplasm 4Gastrointestinal 4Genitourinary 3Head & Neck 2CNS 1

Conditions

Breast Neoplasms 2Anatomic Stage IV Breast Cancer AJCC v8 2Carcinoma, Intraductal, Noninfiltrating 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Trastuzumab 732Paclitaxel 695Cyclophosphamide 647Docetaxel 560Capecitabine 486Letrozole 437Fulvestrant 400Carboplatin 398Doxorubicin 341Tamoxifen 308Anastrozole 279pembrolizumab 274exemestane 258Epirubicin 251pertuzumab 240Radiotherapy 239palbociclib 224Bevacizumab 222Gemcitabine 215Vinorelbine 197Lapatinib 181130-nm albumin-bound paclitaxel 172Magnetic Resonance Spectroscopy 164Albumin-Bound Paclitaxel 157eribulin 154Surveys and Questionnaires 152Exercise 151Drug Therapy 141Taxes 134Fluorouracil 133

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Steroids × Breast × Clear all
NCT07578116 2026-05-27

Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis

SWOG Cancer Research Network

Phase 3 Not yet recruiting
562 enrolled
Breast

Anatomic Stage IV Breast Cancer AJCC v8

NCT07112053 2026-04-06

A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer

University of Washington

Phase 2 Recruiting
40 enrolled
Breast

Anatomic Stage IV Breast Cancer AJCC v8

NCT07407920 2026-02-12

Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
120 enrolled
Breast

Anatomic Stage I Breast Cancer AJCC v8

NCT02352883 2025-12-19

MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ

Eastern Cooperative Oncology Group

Phase NA Active not recruiting
368 enrolled
Breast

Carcinoma, Intraductal, Noninfiltrating

NCT04019834 2022-08-03

RELIEF

University of Alabama at Birmingham

Phase EARLY_PHASE1 Completed
21 enrolled
Breast

Breast Neoplasms

NCT04640220 2022-01-10

Improvement of Range of Motion in Frozen Shoulder in Breast Cancer Survivors

Yeungnam University Hospital

Phase NA Completed
28 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡